News

Find News

Filter articles

Showing 1 to 10 of 2425 results

Strawberry breeder accuses competitor of patent infringement

US22-03-2019

A California-based company which breeds berries has filed a patent infringement claim against a competitor.

CJEU puts further breaks on SPCs

EU22-03-2019

The Court of Justice of the European Union yesterday, March 21, handed down a supplementary protection certificate decision referred to it by the English High Court.

Seven new drugs to join $1bn club by 2021, says Clarivate

US21-03-2019

Seven new drugs are forecasted to achieve annual sales of $1 billion or more by 2023, according to a new report.

WHO to begin working on gene editing research registry

International21-03-2019

World Health Organization (WHO) experts have called for central registry on human genome editing research is needed, among a committee consensus that it would be irresponsible for any scientist to conduct gene-editing studies in people.

EU court backs medical device company over EUIPO

EU21-03-2019

The EU General Court yesterday, March 20, annulled a European Union Intellectual Property Office (EUIPO) decision and handed a trademark victory to Spain-based Prim.

Allergan and tribe hit back at Mylan claims in SCOTUS brief

US20-03-2019

Allergan and the Saint Regis Mohawk Tribe have again urged the US Supreme Court to hear their closely-followed litigation on tribal sovereign immunity, following a submission from generic maker Mylan in the case.

SCOTUS to hear pharmaceutical patent dispute

US19-03-2019

The US Supreme Court will seek the advice of the country’s solicitor general after it agreed to hear an appeal in a dispute over whether a medical treatment is directed towards a natural law.

Teva enters settlement with Novo Nordisk to sell Victoza generic

US19-03-2019

Danish pharmaceutical company Novo Nordisk and generics maker Teva have reached a settlement in their US dispute over Victoza.

Federal Circuit rules ‘treatment claims’ are patent eligible

US18-03-2019

The US Court of Appeals for the Federal Circuit has warned against implementing “too broad” an interpretation of the Alice test as it ruled that “treatment claims” were eligible for patenting.

Federal Circuit sends Allergan’s patent dispute back to district court

US18-03-2019

A district court must revisit its decision that one of Allergan’s patents is valid and was not infringed by a competitor.

Showing 1 to 10 of 2425 results

LSIPR